Exact Mass: 298.1681

Exact Mass Matches: 298.1681

Found 61 metabolites which its exact mass value is equals to given mass value 298.1681, within given mass tolerance error 4.0E-5 dalton. Try search metabolite list with more accurate mass tolerance error 8.0E-6 dalton.

Fumigaclavine A

4,6-Dimethyl-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),9,12,14-tetraen-3-yl acetic acid

C18H22N2O2 (298.1681)


Fumigaclavine A is an alkaloid from Aspergillus fumigatu Fumigaclavine A. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=6879-59-0 (retrieved 2024-08-26) (CAS RN: 6879-59-0). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).

   

2,9-Dimethyl-2,9-diazatricyclo[10.2.2.25,8]octadeca-5,7,12,14,15,17-hexaene-3,10-diol, 9CI

2,9-Dimethyl-2,9-diazatricyclo[10.2.2.25,8]octadeca-5,7,12,14,15,17-hexaene-3,10-diol, 9CI

C18H22N2O2 (298.1681)


2,9-Dimethyl-2,9-diazatricyclo[10.2.2.25,8]octadeca-5,7,12,14,15,17-hexaene-3,10-diol, 9CI is found in citrus. 2,9-Dimethyl-2,9-diazatricyclo[10.2.2.25,8]octadeca-5,7,12,14,15,17-hexaene-3,10-diol, 9CI is an alkaloid from peelings of Citrus unshiu (satsuma mandarin). Alkaloid from peelings of Citrus unshiu (satsuma mandarin). 2,9-Dimethyl-2,9-diazatricyclo[10.2.2.25,8]octadeca-5,7,12,14,15,17-hexaene-3,10-diol, 9CI is found in citrus.

   

Carazolol

1-(9H-carbazol-4-yloxy)-3-[(propan-2-yl)amino]propan-2-ol

C18H22N2O2 (298.1681)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists Carazolol is a β1/β2 adrenoceptor antagonist of high potency used in the research of hypertension. Carazolol is also a potent, selective β3-adrenoceptor agonist[1].

   

N,alpha,N,alpha-Cyclodi(4-methylaminobenzeneethanol)

N,alpha,N,alpha-Cyclodi(4-methylaminobenzeneethanol)

C18H22N2O2 (298.1681)


   

Carazolol

Carazolol

C18H22N2O2 (298.1681)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists Carazolol is a β1/β2 adrenoceptor antagonist of high potency used in the research of hypertension. Carazolol is also a potent, selective β3-adrenoceptor agonist[1].

   

Maybridge3_002255

Maybridge3_002255

C18H22N2O2 (298.1681)


   

Methoxydoisuthine

Methoxydoisuthine

C18H22N2O2 (298.1681)


   

Strychnochromine

Strychnochromine

C18H22N2O2 (298.1681)


   
   

6,9-Dimethyl-7-O-acetylergolin|9alpha-acetoxy-6,8beta-dimethyl-ergoline|Roquefortin A|roquefortine-A

6,9-Dimethyl-7-O-acetylergolin|9alpha-acetoxy-6,8beta-dimethyl-ergoline|Roquefortin A|roquefortine-A

C18H22N2O2 (298.1681)


   

trans-2,5-bis<(p-hydroxyphenyl)methyl>piperazine|trans-2,5-bis[(p-hydroxyphenyl)methyl]piperazine

trans-2,5-bis<(p-hydroxyphenyl)methyl>piperazine|trans-2,5-bis[(p-hydroxyphenyl)methyl]piperazine

C18H22N2O2 (298.1681)


   

dehydroodorin|Dehydroodorine

dehydroodorin|Dehydroodorine

C18H22N2O2 (298.1681)


   

(E)-N-[4-(3-methyl-2-oxo-2,5-dihydro-1H-pyrrol-1-yl)-butyl]-3-phenyl-2-propenamide|aglairubine

(E)-N-[4-(3-methyl-2-oxo-2,5-dihydro-1H-pyrrol-1-yl)-butyl]-3-phenyl-2-propenamide|aglairubine

C18H22N2O2 (298.1681)


   

Roquefortine A

Roquefortine A

C18H22N2O2 (298.1681)


CONFIDENCE isolated standard

   

Fumigaclavine A

4,6-dimethyl-6,11-diazatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadeca-1(16),9,12,14-tetraen-3-yl acetate

C18H22N2O2 (298.1681)


An ergot alkaloid produced by the fungus Aspergillus fumigatus that is ergoline which is substituted by methyl groups at the 6 and 8beta positions, and by an acetoxy group at the 9beta position.

   

N,a',N',a-Cyclodi(4-methylaminobenzeneethanol)

2,9-dimethyl-2,9-diazatricyclo[10.2.2.2^{5,8}]octadeca-1(14),5,7,12,15,17-hexaene-3,10-diol

C18H22N2O2 (298.1681)


   

1-(4-AMINOPHENYL)METHANESULFONAMIDE

1-(4-AMINOPHENYL)METHANESULFONAMIDE

C18H22N2O2 (298.1681)


   

1-Carbazol-9-yl-3-(2-methoxy-ethylamino)-propan-2-ol

1-Carbazol-9-yl-3-(2-methoxy-ethylamino)-propan-2-ol

C18H22N2O2 (298.1681)


   

2-methyl-1-[2-(4-methylpiperidin-1-yl)-2-oxoethyl]indole-3-carbaldehyde

2-methyl-1-[2-(4-methylpiperidin-1-yl)-2-oxoethyl]indole-3-carbaldehyde

C18H22N2O2 (298.1681)


   

Phenacaine

holocalin(p)

C18H22N2O2 (298.1681)


C78272 - Agent Affecting Nervous System > C245 - Anesthetic Agent

   

ISOPROPYL 1,1-DIMETHYL-1,2,3,6-TETRAHYDROAZEPINO[4,5-B]INDOLE-5-CARBOXYLATE

ISOPROPYL 1,1-DIMETHYL-1,2,3,6-TETRAHYDROAZEPINO[4,5-B]INDOLE-5-CARBOXYLATE

C18H22N2O2 (298.1681)


   

1-Diphenylmethylazetidin-3-amine acetate

1-Diphenylmethylazetidin-3-amine acetate

C18H22N2O2 (298.1681)


   

2-[4-(1-METHYL-1-PHENYLETHYL)PHENOXY]PROPANOHYDRAZIDE

2-[4-(1-METHYL-1-PHENYLETHYL)PHENOXY]PROPANOHYDRAZIDE

C18H22N2O2 (298.1681)


   

N-cyclohexyl-2-(3-formyl-2-methylindol-1-yl)acetamide

N-cyclohexyl-2-(3-formyl-2-methylindol-1-yl)acetamide

C18H22N2O2 (298.1681)


   

3-(3-CARBAZOL-9-YL-2-HYDROXY-PROPYLAMINO)-PROPAN-1-OL

3-(3-CARBAZOL-9-YL-2-HYDROXY-PROPYLAMINO)-PROPAN-1-OL

C18H22N2O2 (298.1681)


   

(-)-BIS[(S)-1-PHENYLETHYL]AMINEHYDROCHLORIDE

(2s)-1-(9h-Carbazol-4-Yloxy)-3-(Isopropylamino)propan-2-Ol

C18H22N2O2 (298.1681)


   

(+)-B-HYDRASTINEHCL

(+)-B-HYDRASTINEHCL

C18H22N2O2 (298.1681)


   

4-(4-AMINOMETHYL)PHENYL-1-N-BOC-ANILINE

4-(4-AMINOMETHYL)PHENYL-1-N-BOC-ANILINE

C18H22N2O2 (298.1681)


   

tert-Butyl 4-(1H-indol-3-yl)-3,6-dihydropyridine-1(2H)-carboxylate

tert-Butyl 4-(1H-indol-3-yl)-3,6-dihydropyridine-1(2H)-carboxylate

C18H22N2O2 (298.1681)


   

[3-[6-(piperidin-1-ylmethyl)pyridin-2-yl]oxyphenyl]methanol

[3-[6-(piperidin-1-ylmethyl)pyridin-2-yl]oxyphenyl]methanol

C18H22N2O2 (298.1681)


   

1-(2,3-DIMETHYL-INDOL-1-YL)-3-[(FURAN-2-YLMETHYL)-AMINO]-PROPAN-2-OL

1-(2,3-DIMETHYL-INDOL-1-YL)-3-[(FURAN-2-YLMETHYL)-AMINO]-PROPAN-2-OL

C18H22N2O2 (298.1681)


   

(S,S)-2,5-di-(4-hydroxybenzyl)piperazine

(S,S)-2,5-di-(4-hydroxybenzyl)piperazine

C18H22N2O2 (298.1681)


   

2-amino-4-(cyclohex-3-en-1-yl)-7,7-dimethyl-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile

2-amino-4-(cyclohex-3-en-1-yl)-7,7-dimethyl-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile

C18H22N2O2 (298.1681)


   

(R)-pyridin-4-yl[4-(2-pyrrolidin-1-ylethoxy)phenyl]methanol

(R)-pyridin-4-yl[4-(2-pyrrolidin-1-ylethoxy)phenyl]methanol

C18H22N2O2 (298.1681)


   

(8beta,9beta)-6,8-Dimethylergolin-9-yl acetate

(8beta,9beta)-6,8-Dimethylergolin-9-yl acetate

C18H22N2O2 (298.1681)


   

1-(3-Methoxyphenyl)-3-(4-phenylbutyl)urea

1-(3-Methoxyphenyl)-3-(4-phenylbutyl)urea

C18H22N2O2 (298.1681)


   

4-(2-Naphthalenylmethyl)-1-piperazinecarboxylic acid ethyl ester

4-(2-Naphthalenylmethyl)-1-piperazinecarboxylic acid ethyl ester

C18H22N2O2 (298.1681)


   

2-[[3-[(2-Hydroxyphenyl)methyl]-1,3-diazinan-1-yl]methyl]phenol

2-[[3-[(2-Hydroxyphenyl)methyl]-1,3-diazinan-1-yl]methyl]phenol

C18H22N2O2 (298.1681)


   

(6R,7R,8S)-7-[4-(1-cyclopentenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

(6R,7R,8S)-7-[4-(1-cyclopentenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

C18H22N2O2 (298.1681)


   

(6S,7R,8R)-7-[4-(1-cyclopentenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

(6S,7R,8R)-7-[4-(1-cyclopentenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

C18H22N2O2 (298.1681)


   

(6S,7S,8R)-7-[4-(1-cyclopentenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

(6S,7S,8R)-7-[4-(1-cyclopentenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

C18H22N2O2 (298.1681)


   

(6S,7R,8S)-7-[4-(1-cyclopentenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

(6S,7R,8S)-7-[4-(1-cyclopentenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

C18H22N2O2 (298.1681)


   

(6S,7S,8S)-7-[4-(1-cyclopentenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

(6S,7S,8S)-7-[4-(1-cyclopentenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

C18H22N2O2 (298.1681)


   

(6R,7S,8S)-7-[4-(1-cyclopentenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

(6R,7S,8S)-7-[4-(1-cyclopentenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

C18H22N2O2 (298.1681)


   

(6R,7R,8R)-7-[4-(1-cyclopentenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

(6R,7R,8R)-7-[4-(1-cyclopentenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

C18H22N2O2 (298.1681)


   

(6R,7S,8R)-7-[4-(1-cyclopentenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

(6R,7S,8R)-7-[4-(1-cyclopentenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

C18H22N2O2 (298.1681)


   

4,4-Hexamethylene-2-para-tolylperhydropyrrolo(3,4-C)pyrrole-1,3-dione

4,4-Hexamethylene-2-para-tolylperhydropyrrolo(3,4-C)pyrrole-1,3-dione

C18H22N2O2 (298.1681)


   

5-Methyl-4,4-tetramethylene-2-para-tolylperhydropyrrolo(3,4-C)pyrrole-1,3-dione

5-Methyl-4,4-tetramethylene-2-para-tolylperhydropyrrolo(3,4-C)pyrrole-1,3-dione

C18H22N2O2 (298.1681)


   

2,9-Dimethyl-2,9-diazatricyclo[10.2.2.25,8]octadeca-5,7,12,14,15,17-hexaene-3,10-diol, 9CI

2,9-Dimethyl-2,9-diazatricyclo[10.2.2.25,8]octadeca-5,7,12,14,15,17-hexaene-3,10-diol, 9CI

C18H22N2O2 (298.1681)


   

(2s,3r,4s,7r)-4,6-dimethyl-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),9,12,14-tetraen-3-yl acetate

(2s,3r,4s,7r)-4,6-dimethyl-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),9,12,14-tetraen-3-yl acetate

C18H22N2O2 (298.1681)


   

9-(2-hydroxyethyl)-8,15-diazapentacyclo[10.5.1.0¹,⁹.0²,⁷.0¹⁵,¹⁸]octadeca-2,4,6-trien-10-one

9-(2-hydroxyethyl)-8,15-diazapentacyclo[10.5.1.0¹,⁹.0²,⁷.0¹⁵,¹⁸]octadeca-2,4,6-trien-10-one

C18H22N2O2 (298.1681)


   

n-[2-(4-methoxyphenyl)ethyl]-n-methyl-2-(methylamino)benzamide

n-[2-(4-methoxyphenyl)ethyl]-n-methyl-2-(methylamino)benzamide

C18H22N2O2 (298.1681)


   

(2e)-2-methyl-n-[(2r)-1-[(2e)-3-phenylprop-2-enoyl]pyrrolidin-2-yl]but-2-enimidic acid

(2e)-2-methyl-n-[(2r)-1-[(2e)-3-phenylprop-2-enoyl]pyrrolidin-2-yl]but-2-enimidic acid

C18H22N2O2 (298.1681)


   

(1r,9s,12s,18s)-9-(2-hydroxyethyl)-8,15-diazapentacyclo[10.5.1.0¹,⁹.0²,⁷.0¹⁵,¹⁸]octadeca-2,4,6-trien-10-one

(1r,9s,12s,18s)-9-(2-hydroxyethyl)-8,15-diazapentacyclo[10.5.1.0¹,⁹.0²,⁷.0¹⁵,¹⁸]octadeca-2,4,6-trien-10-one

C18H22N2O2 (298.1681)


   

2-methyl-n-[1-(3-phenylprop-2-enoyl)pyrrolidin-2-yl]but-2-enimidic acid

2-methyl-n-[1-(3-phenylprop-2-enoyl)pyrrolidin-2-yl]but-2-enimidic acid

C18H22N2O2 (298.1681)


   

9-(2-hydroxyethyl)-8,11-diazapentacyclo[9.5.2.0¹,¹⁰.0²,⁷.0⁹,¹⁴]octadeca-2,4,6-trien-16-one

9-(2-hydroxyethyl)-8,11-diazapentacyclo[9.5.2.0¹,¹⁰.0²,⁷.0⁹,¹⁴]octadeca-2,4,6-trien-16-one

C18H22N2O2 (298.1681)


   

(1s,9s,10r,14r)-9-(2-hydroxyethyl)-8,11-diazapentacyclo[9.5.2.0¹,¹⁰.0²,⁷.0⁹,¹⁴]octadeca-2,4,6-trien-16-one

(1s,9s,10r,14r)-9-(2-hydroxyethyl)-8,11-diazapentacyclo[9.5.2.0¹,¹⁰.0²,⁷.0⁹,¹⁴]octadeca-2,4,6-trien-16-one

C18H22N2O2 (298.1681)


   

(2e)-n-[4-(3-methyl-2-oxo-5h-pyrrol-1-yl)butyl]-3-phenylprop-2-enimidic acid

(2e)-n-[4-(3-methyl-2-oxo-5h-pyrrol-1-yl)butyl]-3-phenylprop-2-enimidic acid

C18H22N2O2 (298.1681)


   

(2r,3r,4r,7s)-4,6-dimethyl-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),9,12,14-tetraen-3-yl acetate

(2r,3r,4r,7s)-4,6-dimethyl-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),9,12,14-tetraen-3-yl acetate

C18H22N2O2 (298.1681)


   

(2r,3s,4s,7r)-4,6-dimethyl-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),9,12,14-tetraen-3-yl acetate

(2r,3s,4s,7r)-4,6-dimethyl-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),9,12,14-tetraen-3-yl acetate

C18H22N2O2 (298.1681)


   

(2r,3r,4r,7r)-4,6-dimethyl-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),9,12,14-tetraen-3-yl acetate

(2r,3r,4r,7r)-4,6-dimethyl-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),9,12,14-tetraen-3-yl acetate

C18H22N2O2 (298.1681)